ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number3232
Number of pages18
JournalCancers
Volume13
Issue number13
DOIs
Publication statusPublished - Jul 2021

Keywords

  • alloreactive donor NK cells
  • HLA class I
  • antibody-dependent cellular cytotoxicity
  • breast cancer
  • tumor microenvironment
  • CLASS-I
  • TUMOR HYPOXIA
  • EXPRESSION
  • TRANSPLANTATION
  • INHIBITION
  • RECEPTORS
  • SELF

Cite this